{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:42:04Z","timestamp":1769110924484,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003129","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000}}],"reference-count":79,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003129.pub2","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T07:06:29Z","timestamp":1707462389000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Methotrexate for juvenile idiopathic arthritis"],"prefix":"10.1002","volume":"2024","author":[{"given":"Joachim","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology; Children's Health Queensland; South Brisbane Australia"},{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D","family":"Renton","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"},{"name":"Rheumatology Unit, Department of General Medicine; The Royal Children's Hospital; Melbourne Australia"},{"name":"Department of Paediatric Rheumatology; Monash Children's Hospital; Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel L","family":"Whittle","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"},{"name":"Department of Rheumatology; The Queen Elizabeth Hospital and University of Adelaide; Woodville Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Takken","sequence":"additional","affiliation":[{"name":"Child Development and Exercise Center; Wilhelmina Children's Hospital, University Medical Center Utrecht; Utrecht Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renea V","family":"Johnston","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Tiller","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"},{"name":"Rheumatology Unit, Department of General Medicine; The Royal Children's Hospital; Melbourne Australia"},{"name":"Department of Paediatric Rheumatology; Monash Children's Hospital; Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Munro","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"},{"name":"Rheumatology Unit, Department of General Medicine; The Royal Children's Hospital; Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"10.1002\/14651858.CD003129.pub2-BIB0001|cit1","first-page":"30","article-title":"Methotrexate in juvenile rheumatoid arthritis: randomized, placebo controlled trial","volume":"11","author":"Bharadwaj","year":"2003","journal-title":"Journal of Indian Rheumatology Association"},{"issue":"16","key":"10.1002\/14651858.CD003129.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial","volume":"326","author":"Giannini","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"10072","key":"10.1002\/14651858.CD003129.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(17)30065-X","article-title":"Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial","volume":"389","author":"Ravelli","year":"2017","journal-title":"Lancet"},{"issue":"16","key":"10.1002\/14651858.CD003129.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMoa041810","article-title":"Leflunomide or methotrexate for juvenile rheumatoid arthritis","volume":"352","author":"Silverman","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003129.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","article-title":"Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis","volume":"43","author":"Woo","year":"2000","journal-title":"Arthritis and Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD003129.pub2-BIB0006|cit6","first-page":"1570","article-title":"Influence of food on the bioavailability of oral methotrexate in children","volume":"22","author":"Dupuis","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0007|cit7","unstructured":"Training immune functions through pharmacotherapeutic conditioning in juvenile idiopathic arthritis www.clinicaltrialsregister.eu\/ctr-search\/search?query=2018-001571-21"},{"issue":"13","key":"10.1002\/14651858.CD003129.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","article-title":"Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial","volume":"303","author":"Foell","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD003129.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s003930050216","article-title":"Arbeitsgemeinschaft f\u00fcr Kinder und Jugendrheumatologie (German\/Swiss\/Austrian working group on juvenile rheumatic diseases) presents a design of a prospective controlled trial in children with oligoarthritis type I","volume":"59(2)","author":"Forster","year":"2000","journal-title":"Zeitschrift f\u00fcr Rheumatologie"},{"issue":"6","key":"10.1002\/14651858.CD003129.pub2-BIB0010|cit10","first-page":"435","article-title":"Treatment of patients with juvenile rheumatoid arthritis with combination of leflunomide and methotrexate","volume":"41","author":"Gao","year":"2003","journal-title":"Chinese Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD003129.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/annrheumdis-2018-213902","article-title":"Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial","volume":"78","author":"Hissink Muller","year":"2019","journal-title":"Annals of Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003129.pub2-BIB0012|cit12","first-page":"533","article-title":"Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial","volume":"12","author":"Kvien","year":"1985","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0013|cit13","unstructured":"Strategies towards personalised treatment in Juvenile Idiopathic Arthritis (JIA). (MyJIA) clinicaltrials.gov\/ct2\/show\/NCT04614311"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0014|cit14","unstructured":"Children with arthritis: monotherapy or polytherapy?; June 2016 (updated August 2022) www.onderzoekmetmensen.nl\/en\/trial\/29408"},{"issue":"1","key":"10.1002\/14651858.CD003129.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5114\/reum\/161317","article-title":"Comparison of the efficacy and safety of methotrexate alone or in combination with leflunomide in the treatment of juvenile idiopathic arthritis: a double-blind, placebo-controlled, randomized trial","volume":"61","author":"Rezaieyazdi","year":"2023","journal-title":"Reumatologia"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0016|cit16","unstructured":"Romero ER Galan RA Almagro RM Munoz A Povedano J Treatment of non-infectious uveitis: a comparative long-term study between biologic therapy with adalimumab and two conventional disease-modifying antirheumatic drugs Arthritis & Rheumatology 2017 acrabstracts.org\/abstract\/treatment-of-non-infectious-uveitis-a-comparative-long-term-study-between-biologic-therapy-with-adalimumab-and-two-conventional-disease-modifying-antirheumatic-drugs\/"},{"issue":"7","key":"10.1002\/14651858.CD003129.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis & Rheumatism"},{"issue":"9","key":"10.1002\/14651858.CD003129.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/ard.2010.143347","article-title":"Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial","volume":"70","author":"Tynj\u00e4l\u00e4","year":"2011","journal-title":"Annals of Rheumatic Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003129.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"O23","DOI":"10.1186\/1546-0096-9-S1-O23","article-title":"Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX","volume":"9","author":"Verkaaik","year":"2011","journal-title":"Pediatric Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD003129.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD003129.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12969-022-00739-x","article-title":"Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the \"comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS\" (STARS) trial","volume":"20","author":"Burrone","year":"2022","journal-title":"Pediatric Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD003129.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care and Research"},{"issue":"3","key":"10.1002\/14651858.CD003129.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/BOR.0b013e328329c79d","article-title":"An update on methotrexate","volume":"21","author":"Braun","year":"2009","journal-title":"Current Opinion in Rheumatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003129.pub2-BIB0024|cit24","first-page":"195","article-title":"Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation","volume":"20","author":"Bass","year":"1977","journal-title":"Arthritis & Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0025|cit25","unstructured":"Guidance for the production and publication of Cochrane living systematic reviews: Cochrane Reviews in living mode; December 2019 Available at community.cochrane.org\/sites\/default\/files\/uploads\/inline-files\/Transform\/201912_LSR_Revised_Guidance.pdf"},{"issue":"7","key":"10.1002\/14651858.CD003129.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/art.30367","article-title":"High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score","volume":"63","author":"Bulatovi\u0107","year":"2011","journal-title":"Arthritis & Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD003129.pub2-BIB0027|cit27","first-page":"1","article-title":"The development of classification criteria for children with juvenile rheumatoid arthritis","volume":"38","author":"Cassidy","year":"1989","journal-title":"Bulletin on the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0028|cit28","unstructured":"Cochrane Crowd crowd.cochrane.org"},{"issue":"11","key":"10.1002\/14651858.CD003129.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/acr.22393","article-title":"Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score","volume":"66","author":"Consolaro","year":"2014","journal-title":"Arthritis Care & Research"},{"issue":"1","key":"10.1002\/14651858.CD003129.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12969-016-0085-5","article-title":"Clinical outcome measures in juvenile idiopathic arthritis","volume":"14","author":"Consolaro","year":"2016","journal-title":"Pediatric Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0031|cit31","unstructured":"Covidence Veritas Health Innovation"},{"issue":"3","key":"10.1002\/14651858.CD003129.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0033|cit33","unstructured":"Cochrane Register of Studies (CRS) community.cochrane.org\/help\/tools-and-software\/crs-cochrane-register-studies"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0034|cit34","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0035|cit35","unstructured":"Endnote Clarivate 2020"},{"issue":"1","key":"10.1002\/14651858.CD003129.pub2-BIB0036|cit36","first-page":"7","article-title":"Rheumatoid arthritis in children and related forms. Updating of nomenclature, nosography, clinical manifestations and therapy, with reference to the EULAR\/WHO workshop on the care of rheumatic children, Oslo, March 1977","volume":"29","author":"Fantini","year":"1977","journal-title":"Reumatismo"},{"issue":"1","key":"10.1002\/14651858.CD003129.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12969-018-0255-8","article-title":"Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting","volume":"16","author":"Ferrara","year":"2018","journal-title":"Pediatric Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD003129.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3899\/jrheum.091474","article-title":"Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis","volume":"37","author":"Filocamo","year":"2010","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD003129.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Joint Bone Spine"},{"issue":"7","key":"10.1002\/14651858.CD003129.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis & Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD003129.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/s0022-3476(05)80923-0","article-title":"Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis","volume":"120","author":"Graham","year":"1992","journal-title":"Journal of Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD003129.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010227.pub2","article-title":"Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis","author":"Hazlewood","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003129.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013562","article-title":"Disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a systematic review and network meta-analysis","author":"Hazlewood","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0044|cit44","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"5","key":"10.1002\/14651858.CD003129.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2014.212","article-title":"Management of juvenile idiopathic arthritis: hitting the target","volume":"11","author":"Hinze","year":"2015","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0046|cit46","unstructured":"Renton W An Australian Living Guideline for the Management of Juvenile Idiopathic Arthritis files.magicapp.org\/guideline\/1d74e8af-0ac3-42c5-a9fb-94fc67294150\/published_guideline_6772-0_8.pdf"},{"issue":"8","key":"10.1002\/14651858.CD003129.pub2-BIB0047|cit47","first-page":"1269","article-title":"Reliability and reproducibility of visual analogue scale and numeric rating scale for therapeutic evaluation of pain in rheumatic patients","volume":"18","author":"Joos","year":"1991","journal-title":"Journal of Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD003129.pub2-BIB0048|cit48","first-page":"1845","article-title":"A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing","volume":"20","author":"Jundt","year":"1993","journal-title":"Journal of Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD003129.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/acr.21697","article-title":"Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry","volume":"64","author":"Klein","year":"2012","journal-title":"Arthritis Care & Research"},{"issue":"3","key":"10.1002\/14651858.CD003129.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/bcp.12209","article-title":"Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types","volume":"77","author":"Korell","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD003129.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000957.pub2","article-title":"Methotrexate for treating rheumatoid arthritis","author":"Lopez-Olivo","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD003129.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0053|cit53","unstructured":"MagicApp MagicApp"},{"issue":"8","key":"10.1002\/14651858.CD003129.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3899\/jrheum.181088","article-title":"Establishing an updated core domain set for studies in juvenile idiopathic arthritis: a report from the OMERACT 2018 JIA workshop","volume":"46","author":"Morgan","year":"2019","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0055|cit55","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"3","key":"10.1002\/14651858.CD003129.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10067-013-2389-x","article-title":"Methotrexate-induced nausea and vomiting in adolescent and young adult patients","volume":"33","author":"Patil","year":"2014","journal-title":"Clinical Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD003129.pub2-BIB0057|cit57","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD003129.pub2-BIB0058|cit58","first-page":"390","article-title":"International League of Associations for Rheumatology Classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD003129.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2018-213030","article-title":"Treating juvenile idiopathic arthritis to target: recommendations of an international task force","volume":"77","author":"Ravelli","year":"2018","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0061|cit61","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"issue":"4","key":"10.1002\/14651858.CD003129.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/s0022-3476(05)80709-7","article-title":"Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis","volume":"117","author":"Rose","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"4 Suppl 23","key":"10.1002\/14651858.CD003129.pub2-BIB0063|cit63","first-page":"S1","article-title":"Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology","volume":"19","author":"Ruperto","year":"2001","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD003129.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis & Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD003129.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/art.22709","article-title":"Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor","volume":"56","author":"Saurenmann","year":"2007","journal-title":"Arthritis & Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0066|cit66","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of InterventionsVersion 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0067|cit67","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.20381\/ruor-701","volume-title":"Efficacy and Safety of Pharmacological and Non-Pharmacological Interventions in Juvenile Idiopathic Arthritis: A Series of Systematic Reviews and Network Meta-Analyses [Masters thesis]","author":"Smith","year":"2017"},{"issue":"2","key":"10.1002\/14651858.CD003129.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","article-title":"Prevalence and incidence of juvenile idiopathic arthritis: a systematic review","volume":"81","author":"Thierry","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1002\/14651858.CD003129.pub2-BIB0070|cit70","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis","volume":"65","author":"Tian","year":"2007","journal-title":"Bulletin of the NYU Hospital for Joint Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003129.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12969-018-0288-z","article-title":"Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children","volume":"16","author":"Tiller","year":"2018","journal-title":"Pediatrioc Rheumatology"},{"key":"10.1002\/14651858.CD003129.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12969-015-0002-3","article-title":"Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study","volume":"13","author":"Dijkhuizen","year":"2015","journal-title":"Pediatric Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD003129.pub2-BIB0073|cit73","first-page":"2290","article-title":"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis","volume":"31","author":"Wallace","year":"2004","journal-title":"Journal of Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD003129.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/acr.20497","article-title":"American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis","volume":"63","author":"Wallace","year":"2011","journal-title":"Arthritis Care & Research"},{"issue":"6","key":"10.1002\/14651858.CD003129.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD003129.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/jamia\/ocx053","article-title":"Identifying reports of randomized controlled trials (RCTs) via a hybrid machine learning and crowdsourcing approach","volume":"24","author":"Wallace","year":"2017","journal-title":"Journal of the American Medical Informatics Association"},{"issue":"1","key":"10.1002\/14651858.CD003129.pub2-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012722.pub2","article-title":"Methotrexate for psoriatic arthritis","author":"Wilsdon","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD003129.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/rheumatology\/keh313","article-title":"Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial","volume":"43","author":"Zulian","year":"2004","journal-title":"Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD003129.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003129","article-title":"Methotrexate for treating juvenile idiopathic arthritis","author":"Takken","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:35:27Z","timestamp":1759793727000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003129.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":79,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003129.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]}}}